ResearcherHumanitas UniversityNo recent work listed
Tiziana Comito
Matched on ORCID iD 0000-0002-5667-0535; OpenAlex author ID A5029600028. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 3 papers · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 7
- Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer? Long-Term Clinical Outcomes, Toxicity … Co-author DOI 10.3390/curroncol30070513↗
- The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary Approach With Chemo-Radio Treatments. Co-author DOI 10.1097/mpa.0000000000001907↗
- Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question. First author DOI 10.1259/bjr.20190627↗
- Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective … Co-author DOI 10.1016/j.ejso.2016.12.012↗
- Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials. First author DOI 10.1016/j.ijrobp.2016.10.030↗
- Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a … Co-author DOI 10.1177/1533034616650778↗
- SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. First author DOI 10.1186/1748-717x-8-148↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marta Scorsetti · 6 shared papers, 2013–2023 · strength 0.48
- Paper Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer… DOI 10.3390/curroncol30070513↗
- Paper Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question. DOI 10.1259/bjr.20190627↗
- Paper Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of … DOI 10.1016/j.ijrobp.2016.10.030↗
- Alessandro Zerbi · 5 shared papers, 2013–2023 · strength 0.42
- Paper Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer… DOI 10.3390/curroncol30070513↗
- Paper The Immune Landscape in a Long-Term Survival Pancreatic Adenocarcinoma Patient Highly Responsive to a Multidisciplinary… DOI 10.1097/mpa.0000000000001907↗
- Paper Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic c… DOI 10.1016/j.ejso.2016.12.012↗
- Armando Santoro · 4 shared papers, 2017–2023 · strength 0.36
- Paper Can STEreotactic Body Radiation Therapy (SBRT) Improve the Prognosis of Unresectable Locally Advanced Pancreatic Cancer… DOI 10.3390/curroncol30070513↗
- Paper Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question. DOI 10.1259/bjr.20190627↗
- Paper Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic c… DOI 10.1016/j.ejso.2016.12.012↗
- Silvia Bozzarelli · 2 shared papers, 2020–2023 · strength 0.26
- Maria Ausilia Teriaca · 1 shared paper, 2023 · strength 0.14
- Silvia Carrara · 1 shared paper, 2023 · strength 0.14
- A. Tozzi · 3 shared papers, 2013–2017 · strength 0.14
- Paper Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic c… DOI 10.1016/j.ejso.2016.12.012↗
- Paper Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced … DOI 10.1177/1533034616650778↗
- Paper SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. DOI 10.1186/1748-717x-8-148↗
- Marialuisa Barbagallo · 1 shared paper, 2021 · strength 0.14
- Nina Cortese · 1 shared paper, 2021 · strength 0.14
- Federica Marchesi · 1 shared paper, 2021 · strength 0.14
- Pietro Mancosu · 2 shared papers, 2013–2017 · strength 0.09
- Fausto Petrelli · 1 shared paper, 2017 · strength 0.08
- Sandro Barni · 1 shared paper, 2017 · strength 0.08
- Filippo Alongi · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.